Dr Matthieu Durand
Chirurgien Urologue, Praticien Hospitalier Universitaire
au Centre Hospitalier Universitaire de Nice, il exerce principalement dans le service d’Urologie, Andrologie et Transplantation rénale de l’Hôpital Pasteur 2. Diplômé de Weill Cornell School of Medicine à New-York, après un doctorat de Médecine à la Faculté de Nice Sophia-Antipolis et une formation notamment à l’Institut Mutualiste Montsouris de Paris, il dirige aujourd’hui le développement du programme robotique chirurgical du Centre Hospitalier Universitaire de Nice et assure la coordination urologique du groupement hospitalier de territoire des Alpes Maritimes et la responsabilité des unités d’Hôpital de jour et des soins externes du service de Pasteur 2. Engagé en particulier dans la recherche contre le cancer de la prostate, Dr Matthieu Durand dirige le programme de recherche et les publications de l’équipe du service en développant notamment plusieurs essais cliniques multicentriques nationaux de large envergure promus par le Centre Hospitalier Universitaire de Nice.
INFORMATIONS SUR LA CONSULTATION
- Secrétariat Médical pour prendre rendez-vous : 04.92.03.46.72
- Secrétariat Médical pour prendre rendez-vous : 04.92.03.46.72
- Lundi après-midi au Centre Antoine Lacassagne
- Jeudi toute la journée à l’Hôpital Pasteur 2 – CHU de Nice
CHIRURGIEN UROLOGUE
- Praticien Hospitalier Universitaire (2015) – CHU de Nice, France
- Praticien Hospitalier Contractuel (2014) – CHU de Nice, France
- Chirurgien Urologue (2013) – CHU de Nice, France
- Docteur en médecine (2012) – CHU de Nice, France
- Ancien Fellow en Robotique Urologique (2011) – Weill Cornell School of Medicine de New-York, USA
- Ancien Chef de clinique assistant des Hôpitaux – CHU de Nice, France
- Ancien Interne des Hôpitaux – CHU de Nice, France & Institut Mutualiste Montsouris – Paris, France
ACTIVITÉS, TITRES ACADÉMIQUES & HOSPITALIERS
- Chef Médical du programme robotique du CHU de Nice
- Responsable de l’Unité Fonctionnelle de l’Hôpital de Jour et des Soins Externes d’Urologie du CHU de Nice
- Chercheur associé en génétique somatique des tumeurs solides – CNRS UMR 7284 / Institut de recherche sur le cancer et le vieillissement de Nice (IRCAN) / INSERM U 1081
- Membre de l’Association Française d’Urologie
- Membre de l’Association Européenne d’Urologie
- DESC d’Urologie – Université de Nice-Sophia-Antipolis (2012)
- Fellowship Prostatectomy Robotic – Weill Cornell School of Medicine (2011)
- DES de Chirurgie Générale – Université de Nice-Sophia-Antipolis (2009)
- Master 2 Recherche : Sciences Chirurgicales Paris VII (2009)
- Master 1 : Sciences de la Vie et de Santé – Université de Nice Sophia-Antipolis (2008)
- DIU d’Urodynamique – Faculté de Bichat, Paris (2007)
RECHERCHE CLINIQUE
- Investigateur principal – Étude IRMK01 (2018)
- Investigateur principal – Étude ARN509-IPC (2018)
- Investigateur principal – Étude PRISME (2018)
- Investigateur principal – Étude DUO (2017)
- Investigateur associé – Étude HIFI (2015)
- Auteur, coordonnateur et investigateur principal – Étude PRECOCE (2014)
- Investigateur principal – Etude P00048 GP 4 04 (PERLES) (2014)
- Investigateur principal – Etude P00048 GP 4 03 (PERMIXON) (2012)
ACTIVITÉS D’ENSEIGNEMENTS
- Enseignement de l’Urologie étudiants 1er et 2ème cycle à la Faculté de Médecine de Nice Sophia-Antipolis
- Conférencier à la Faculté de Médecine de Nice Sophia-Antipolis pour la préparation à l’Épreuve Nationale Classante (ECN)
- Membre pédagogique SIDES à la Faculté de Médecine de Nice Sophia-Antipolis
COMMUNICATIONS ORALES & POSTERS
- High-resolution magnetic resonance imaging differentiates between normal histomorphological signatures and prostate cancer in the resected prostate gland. Durand M et al. Moderated Poster 16 – AUA 2016 (San Diego, USA)
- High-resolution magnetic resonance imaging differentiates between normal histomorphological signatures and prostate cancer in the resected prostate gland. Durand M et al. Poster session 62. Abstract n°783. EAU 2016 (Munich, Allemagne)
- Ejaculation preservation following robotic prostatectomy: description of a novel technique and preliminary results. Durand M et al. Moderated Poster – 1824 – AUA 2012 (Atlanta, GA USA)
- High Resolution Magnetic Resonance Imaging of Human Radical Prostatectomy Specimens. Durand M et al. Moderated Poster – 1627 – AUA 2012 (Atlanta, GA USA)
- Real-time, in vivo multiphoton microscopy imaging is a promising tool to identify prostate tissue during rat survival surgery. Durand M et al. Poster session 20. Abstract n°246. EAU 2012 (Paris)
- Multiphoton microscopy provides virtual histology of prostatic and periprostatic structures in human radical prostatectomy specimens. Durand M et al. Moderated Poster session – EAU 2012 (Paris)
- In vivo real-time multiphoton microscopy imaging is a safe tool to identify clinically relevant prostatic anatomy during rodent survival surgery. Durand M et al. 30th WCE 2012 (Istanbul, Turkey)
- Focal Cryotherapy: An Optional Treatment For Unilateral Low-Risk Prostate Cancer. Durand M et al. 5th International Symposium on Focal Therapy (Durham, NC, USA) 6th-8th 2012 – MP40-02 30th WCE 2012 (Istanbul, Turkey)
- Multiphoton microscopy provides virtual histology of prostatic and periprostatic structures in human radical prostatectomy specimens. Durand M et al. Moderated Poster session 52 – AUA 2011 (Washington) – 01/05/2011 – PCF 2011
- Multiphoton microscopy for identification of Prostatic and Periprostatic structures in human radical prostatectomy specimens. Durand M et al. AUA 2011 (Washington)
PUBLICATIONS & OUVRAGES SCIENTIFIQUES
- Safety of dual kidney transplantation compared to single kidney transplantation from expanded criteria donors: a single center cohort study of 39 recipients. Mendel L, Albano L, Bentellis I, Yandza T, Bernardi C, Quintens H, Tibi B, Jourdan J, Durand M, Amiel J, Chevallier D. Transpl Int. (2018)
- Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study. Demonchy E, Courjon J, Ughetto E, Durand M, Risso K, Garraffo R, Roger PM. Int J Antimicrob Agents (2018)
- ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review. Bodokh Y, Ambrosetti D, Kubiniek V, Tibi B, Durand M, Amiel J, Pertuit M, Barlier A, Pedeutour F. Cancer Genet. (2018)
- Outcome of Transurethral Resection of Bladder Tumor: Does Antiplatelet Therapy Really Matter? Analysis of a Retrospective Series. Prader R, De Broca B, Chevallier D, Amiel J, Durand M. J Endourol. (2017)
- Sirtuin 7: a new marker of aggressiveness in prostate cancer. Haider R, Massa F, Kaminski L, Clavel S, Djabari Z, Robert G, Laurent K, Michiels JF, Durand M, Ricci JE, Tanti JF, Bost F, Ambrosetti D. Oncotarget (2017)
- Comprehensive study of three novel cases of TFEB-amplified renal cell carcinoma and review of the literature: evidence for a specific entity with poor outcome. Mendel L, Ambrosetti D, Bodokh Y, Ngo-Mai M, Durand M, Simbsler-Michel C, Delhorbe M, Amiel J, Pedeutour F. Genes Chromosomes Cancer (2017)
- Percutaneous nephrolithotomy for kidney stones in elderly patients: Meta-analysis of results and complications. Haider R, Regnier P, Roustan FR, Séverac F, Treacy PJ, Mendel L, Bodokh Y, Tibi B, Prader R, Traxer O, Chevallier D, Amiel J, Durand M. Prog Urol. (2017)
- Quantified analysis of histological components and architectural patterns of gleason grades in apparent diffusion coefficient restricted areas upon diffusion weighted MRI for peripheral or transition zone cancer locations. Helfrich O, Puech P, Betrouni N, Pinçon C, Ouzzane A, Rizk J, Marcq G, Randazzo M, Durand M, Lakroum S, Leroy X, Villers A. J Magn Reson Imaging. (2017)
- Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy. Mbeutcha A, Chauveinc L, Bondiau PY, Chand ME, Durand M, Chevallier D, Amiel J, Kee DL, Hannoun-Lévi JM. Radiat Oncol. (2017)
- Magnetic resonance microscopy may enable distinction between normal histomorphological features and prostate cancer in the resected prostate gland. Durand M, Jain M, Robinson B, Aronowitz E, El Douahy Y, Leung R, Scherr DS, Ng A, Donzeau D, Amiel J, Spincemaille P, Villers A, Ballon DJ. BJU Int. (2017)
- A comparison of magnetic resonance imaging and ultrasonography (MRI/US)-fusion guided prostate biopsy devices: too many uncontrolled variables.Rastinehad AR, Durand M. BJU Int. (2016)
- Endoureteral Management of Renal Graft Ureteral Stenosis by the Use of Long-Term Metal Stent: An Appealing Treatment Option. Treacy PJ, Rastinehad AR, Imbert de la Phalecque L, Albano L, Durand M. J Endourol Case Rep. (2016)
- Technical Aspects of Focal Therapy Localized in Prostate Cancer, Springer, Barret E & Durand M (2015)
- Corrigendum re: « effect of a risk-stratified grade of nerve-sparing technique on early return of continence after robot-assisted laparoscopic radical prostatectomy » Srivastava A, Chopra S, Pham A, Sooriakumaran P, Durand M, Chughtai B, Gruschow S, Peyser A, Harneja N, Leung R, Lee R, Herman M, Robinson B, Shevchuk M, Tewari A. Eur Urol. (2015)
- Real-time in vivo periprostatic nerve tracking using multiphoton microscopy in a rat survival surgery model: a promising pre-clinical study for enhanced nerve-sparing surgery. Durand M et al. BJU Int. (2014)
- A rare case of histopathological bladder necrosis associated with Actinobaculum schaalii: The incremental value of an accurate microbiological diagnosis using 16S rDNA sequencing. Lotte R, Durand M et al. Anaerobe. (2014)
- Focal Cryoablation: A Treatment Option For Unilateral Low-Risk Prostate Cancer. Durand M et al. BJU Int. (2013)
- High-resolution magnetic resonance imaging of prostatectomy specimens: a promising tool for virtual histology. Durand M et al. Eur Urol. (2012)
